Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Trigeminal neuralgia: A new therapy?
A molecular view of multiple sclerosis and experimental autoimmune encephalitis: What can we learn from the epitope data?
Protective and Detrimental Roles for Regulatory T Cells in a Viral Model for Multiple Sclerosis.
Induction of Experimental Autoimmune Encephalomyelitis With Recombinant Human Myelin Oligodendrocyte Glycoprotein in Incomplete Freund's Adjuvant in Three Non-human Primate Species.
Genetic variation near IRF8 is associated with serologic and cytokine profiles in systemic lupus erythematosus and multiple sclerosis.
Optic neuritis combined with hepatitis B and neurosyphilis.
Therapeutic targeting of STAT pathways in CNS autoimmune diseases.
Resilience, self-efficacy, coping styles and depressive and anxiety symptoms in those newly diagnosed with multiple sclerosis.
Zinc sulphate: A reasonable choice for depression management in patients with multiple sclerosis: A randomized, double-blind, placebo-controlled clinical trial.
Possible Role of Staphylococcal Enterotoxin B in the Pathogenesis of Autoimmune Diseases.
Distilling the essence of appraisal: a mixed methods study of people with multiple sclerosis.
Myelination Is Associated with Processing Speed in Early Childhood: Preliminary Insights.
A subject-specific framework for in vivo myeloarchitectonic analysis using high resolution quantitative MRI.
Correction: The Synergistic Local Immunosuppressive Effects of Neural Stem Cells Expressing Indoleamine 2,3-Dioxygenase (IDO) in an Experimental Autoimmune Encephalomyelitis (EAE) Animal Model.
Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease.
Somatosensory temporal discrimination threshold is impaired in patients with multiple sclerosis.
Gray Matter Involvement in Radiologically Isolated Syndrome.
A Bayesian hierarchical surrogate outcome model for multiple sclerosis.
Can a physician predict the clinical response to first-line immunomodulatory treatment in relapsing-remitting multiple sclerosis?
Clinical prospective study of visual function in patients with acute optic neuritis.
Oculopalatal tremor in multiple sclerosis with spontaneous resolution.
Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging.
Immunoadsorption therapy for neuromyelitis optica spectrum disorders long after the acute phase.
Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination.
Rehabilitation interventions for the management of multiple sclerosis relapse: a short scoping review.
Pages
« first
‹ previous
…
425
426
427
428
429
430
431
432
433
…
next ›
last »